{"name": "sitafloxacin", "category": "drug", "content": "Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market.  Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.   == See also == Quinolone   == References ==   == Further reading == Keating GM (April 2011). \"Sitafloxacin: in bacterial infections\". Drugs. 71 (6): 731\u201344. doi:10.2165/11207380-000000000-00000. PMID 21504249. S2CID 195688876.   == External links == (in Japanese) Gracevit \u30b0\u30ec\u30fc\u30b9\u30d3\u30c3\u30c8 (PDF) Daiichi Sankyo Co. January 2008."}